Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Stock indices matter because they summarize broad market performance, guide diversification, and influence risk assessments for investors.
27,507 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
Occidental Petroleum surges in 2026 on debt cleanup after the OxyChem sale, with oil prices supportive but questions ...
Bitcoin keeps rallying mid-month as a financing loop tied to STRC drives fresh BTC purchases by Strategy, intensifyin...
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
IBM has fallen roughly 16% from its January peak as cash flow improves and software growth accelerates. This piece we...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Greg Abel is moving Berkshire Hathaway beyond its familiar bets. After a bold $23 billion purchase in a single stock,...
BYD’s Q2 2026 results set a new pace for electric vehicles, with a headline figure of 557,090 BEVs. This shift challe...
A once-dismissed Google-backed AI fund has closed a $220 million fifth fund, illustrating how the seeds of AI investi...
Nvidia's GTC keynote spotlighted agentic AI and robotics, laying out a future where startups must adapt to new comput...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...